TriOar is a biotech company focusing on developing next-generation antibody-based therapeutics with novel platform technologies.

Greetings,

I am delighted to extend a warm welcome to you as the CEO & president of TriOar.
At the forefront of our mission is the relentless pursuit of groundbreaking solutions in the field of biotechnology, specially in the development of anti-cancer drugs using novel platform technologies.

In a world where the fight against cancer demands unwavering dedication and innovation, we stand commited to making a profound impact. Our approach revloves around pushing the boundaries of what is possible, driven by steadfast commitment to fufill the unmet needs in cancer treatment.

At TriOar, we are giuded by a vision of ushering in a new era in healthcare -one where patients facing the challenges of cancer can find hope and healing through cutting-edge therapies. Our novel platform technologies represent the culmination of extensive research, technological prowess, and unyielding determination to make a meaningful difference.

We recognize the urgency of our mission and the lives that depends on the advancements we strive to achieve. With the core values of Insight, Faith, and Resilience we stand for, we are dedicated to bringing forth innovative anti-cancer drugs that will redefine the landscape of oncology care.

As we embark on this transformative journey, we invite you to join us in our pursuit of a future where cancer is met with unprecedented resilience and effective, compassionate solutions. Together, let us shape a world where unmet needs become opportunities for healing, and where innovation paves the way for a brighter, healthier tomorrow.

Thank you for being a part of our journey.

Sincerely,

SUNG HO WOO Ph.D. CEO & President TriOar Inc.